GHK-Cu dosage in clinical and research contexts typically ranges from 0.5 to 3 mg administered monthly via subcutaneous injection, though individual protocols vary based on treatment goals and baseline health markers
10.1016/s0140-6736(23)00966-2 27 LiH
skin biology research
Test compound and/or vehicle is preincubated with 20 g/ml enzyme in modified phosphate buffer pH 6.5 for 15 minutes at 37C
Buying excessive quantities that sit for years before use risks degradation even in ideal storage
doi: 10.1080/17425255.2023.2223959 [PubMed] 37552484 Dart RC, Mullins ME, Matoushek T, Ruha AM, Burns MM, Simone K, Beuhler MC, Heard KJ, Mazer-Amirshahi M, Stork CM, Varney SM, Funk AR, Cantrell LF, Cole JB, Banner W, Stolbach AI, Hendrickson RG, Lucyk SN, Sivilotti MLA, Su MK, Nelson LS, Rumack BH